Welcome to the Reuters.com BETA. Read our Editor's note on how we're helping professionals make smart decisions.
Skip to main content

United States

U.S. advisory panel makes no decision on pause to J&J's COVID-19 vaccine

1 minute read

April 14 (Reuters) - A U.S. health advisory panel on Wednesday did not make a decision related to the pause in the use of Johnson & Johnson's (JNJ.N) COVID-19 vaccine, and aimed to reconvene possibly in a week or 10 days.

Reporting by Manas Mishra in Bengaluru Editing by Chris Reese

Our Standards: The Thomson Reuters Trust Principles.

More from Reuters